P. Ranji

发表

Citriquinones A and B, New Benzoquinones from Penicillium Citrinum

G. Gunaherath, P. Ranji, S. C. Wijeyaratne, 2013, Natural product communications.

Inhibition of the mevalonate pathway in C. elegans: Consequences and implications

P. Ranji, 2015 .

Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo

A. Ståhlberg, P. Åman, S. Dolatabadi, 2022, Biomedicines.

Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment.

E. Larsson, P. Fitzpatrick, G. Landberg, 2019, Biomaterials.

Patient‐derived scaffolds as a model of colorectal cancer

G. Landberg, A. Ståhlberg, Simona Salerno, 2020, Cancer medicine.

Correction: Caenorhabditis elegans PAQR-2 and IGLR-2 Protect against Glucose Toxicity by Modulating Membrane Lipid Composition

J. Borén, M. Ståhlman, M. Pilon, 2016, PLoS genetics.

Caenorhabditis elegans PAQR-2 and IGLR-2 Protect against Glucose Toxicity by Modulating Membrane Lipid Composition

J. Borén, M. Ståhlman, M. Pilon, 2016, PLoS genetics.

The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway

M. Pilon, Manish Rauthan, P. Ranji, 2013, Proceedings of the National Academy of Sciences.

A Mutation in Caenorhabditis elegans NDUF-7 Activates the Mitochondrial Stress Response and Prolongs Lifespan via ROS and CED-4

M. Pilon, Manish Rauthan, P. Ranji, 2015, G3: Genes, Genomes, Genetics.

Loss of HMG-CoA Reductase in C. elegans Causes Defects in Protein Prenylation and Muscle Mitochondria

M. Pilon, Manish Rauthan, P. Ranji, 2014, PloS one.

Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development

S. Dolatabadi, S. Filges, Emma Jonasson, 2024, Journal of translational medicine.

Characterization of cell-free breast cancer patient-derived scaffolds using liquid chromatography-mass spectrometry/mass spectrometry data and RNA sequencing data

E. Larsson, P. Fitzpatrick, G. Landberg, 2020, Data in brief.